4//SEC Filing
ADAMIS ANTHONY P 4
Accession 0001562180-22-005368
CIK 0001314102other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:38 PM ET
Size
7.8 KB
Accession
0001562180-22-005368
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Director
Transactions
- Award
Restricted Stock Units
2022-06-23+6,000→ 6,000 totalExercise: $0.00→ Common Stock (6,000 underlying) - Award
Stock Option (Right to Buy)
2022-06-23+22,000→ 22,000 totalExercise: $7.54Exp: 2032-06-23→ Common Stock (22,000 underlying)
Footnotes (2)
- [F1]The restricted stock units will vest in three equal annual installments beginning June 23, 2023.
- [F2]The option becomes exercisable in three ratable annual installments beginning on June 23, 2023.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001277479
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:38 PM ET
- Size
- 7.8 KB